[AsCNP_P4] ポスター4
Bipolar Disorders 1

[AsCNP-P4-3] Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study (ELEVATE extension study)

^○Jun ISHIGOOKA¹, Tadafumi KATO², Mari MIYAJIMA³, Kei WATABE³, Takahiro MASUDA³, Teruhiko HIGUCHI^{4, 5} (1. Institute of CNS Pharmacology, Japan, 2. RIKEN Brain Science Institute, Japan, 3. Sumitomo Dainippon Pharma Co., Ltd., Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)